Skip to main content

Together we are beating cancer

Donate now

Tim Gunn

Tim is a senior digital news officer at Cancer Research UK. He started writing about science after studying English literature at Cambridge and magazine journalism at City, University of London. Before joining the digital news team in August 2022, he was a journalist and medical magazine editor.
Showing 12 out of 58 results
Colourful lollipops on a pink background.

Stand Up To Cancer is funding a team developing a flavoured 'lollipop' test that could help diagnose mouth cancer earlier and much more comfortably. Stand Up To Cancer is funding a team developing a flavoured 'lollipop' test that could help diagnose mouth cancer earlier and much more comfortably.

by Yvonne Ijeh, Tim Gunn | Analysis | 25 October 2024

25 October 2024

This entry is part 2 of 2 in the series Stand Up To Cancer research
A radiotherapy machine in a hospital. It is tilted to show how it can move to target tumours.

A new technique for adapting radiotherapy to the ways our bodies change over time has the potential to cure more bladder cancers while causing fewer side effects, according to one of our latest studies.  A new technique for adapting radiotherapy to the ways our bodies change over time has the potential to cure more bladder cancers while causing fewer side effects, according to one of our latest studies. 

by Tim Gunn | News | 7 October 2024

7 October 2024

A sample of a mouse model of a tumour seen through team Rosetta's tools.

Cancer Grand Challenges team Rosetta found how some of the most aggressive and hard-to-treat breast cancers get the energy they need to grow and spread so quickly. Now we can see about slowing them down for good. Cancer Grand Challenges team Rosetta found how some of the most aggressive and hard-to-treat breast cancers get the energy they need to grow and spread so quickly. Now we can see about slowing them down for good.

by Tim Gunn | In depth | 24 September 2024

24 September 2024

Two women seated in a hospital waiting room

With 300,000 people set to wait longer than they should for treatment over the next five years, the new government needs to improve cancer waiting times performance.  With 300,000 people set to wait longer than they should for treatment over the next five years, the new government needs to improve cancer waiting times performance. 

by Tim Gunn | News | 20 September 2024

20 September 2024

Tesco pharmacists wearing Cancer Research UK-branded
  • Health & Medicine
  • Charity News

Tesco pharmacies are helping spot cancer early

For the September early diagnosis campaign, Tesco customers with unusual symptoms or questions about cancer are invited to get expert information and support while they shop. For the September early diagnosis campaign, Tesco customers with unusual symptoms or questions about cancer are invited to get expert information and support while they shop.

by Tim Gunn | News | 18 September 2024

18 September 2024

A medical professional drawing a dose of a vaccine from a vial with a syringe

LynchVax could help prevent cancer in people with Lynch syndrome, who have a higher risk of bowel cancer, womb cancer and some other types. LynchVax could help prevent cancer in people with Lynch syndrome, who have a higher risk of bowel cancer, womb cancer and some other types.

by Tim Gunn | News | 10 September 2024

10 September 2024

Abdullah, Aleesha-Marie and Faye, who all took part in clinical trials funded by Cancer Research UK

Clinical trials are how we bring better cancer treatments to children and young people. For Childhood Cancer Awareness Month, we asked parents what they're actually like. Clinical trials are how we bring better cancer treatments to children and young people. For Childhood Cancer Awareness Month, we asked parents what they're actually like.

by Tom Bourton, Tim Gunn | Personal stories | 3 September 2024

3 September 2024

A woman reading a cancer information limit while waiting to see the doctor.

Testing women with symptoms that could be linked to ovarian cancer is an effective way of finding aggressive forms of the disease in their early stages, according to research we helped fund. Testing women with symptoms that could be linked to ovarian cancer is an effective way of finding aggressive forms of the disease in their early stages, according to research we helped fund.

by Tim Gunn | News | 15 August 2024

15 August 2024

Brain scans

Stand Up To Cancer are giving two international teams each a further £3.75m to reduce the side effects of radiotherapy and make immunotherapies work for more young patients. Stand Up To Cancer are giving two international teams each a further £3.75m to reduce the side effects of radiotherapy and make immunotherapies work for more young patients.

by Tim Gunn | Analysis | 7 August 2024

7 August 2024

Stained cervical cells viewed under the microscope

More than million more women in England could take part in cervical screening over the next three years if they were offered do-it-yourself kits, according to the YouScreen trial. More than million more women in England could take part in cervical screening over the next three years if they were offered do-it-yourself kits, according to the YouScreen trial.

by Sadaf Shafaghmotlagh, Tim Gunn | News | 17 July 2024

17 July 2024

A crowd of people looking concerned on a hot day.

More UK adults are concerned about cancer than any other medical condition, and most people want to see a future where it can be diagnosed much earlier. More UK adults are concerned about cancer than any other medical condition, and most people want to see a future where it can be diagnosed much earlier.

by Tim Gunn | News | 15 July 2024

15 July 2024

Cancer Research UK scientists in the lab

NHS England will offer the newly-approved dabrafenib plus trametinib combination to children and young people whose gliomas are being driven by a specific genetic mutation. NHS England will offer the newly-approved dabrafenib plus trametinib combination to children and young people whose gliomas are being driven by a specific genetic mutation.

by Tim Gunn | News | 13 June 2024

13 June 2024